Valeant Pharma (VRX) CFO Buys 24K Shares

Valeant Pharma (NYSE: VRX) CFO Paul Herendeen disclosed buying 24,000 shares on 03/14 at $10.72, bringing his stake to 174,000 shares.

The disclosure from Herendeen follows the 3 million share purchase from large and noted investor group ValueAct capital.

POWER OF ATTORNEY







Know all by these presents that the undersigned hereby constitutes and appoints

each of Christina Ackermann. Kelly Webber, D. Alexander Matheson, and

Pamela Chronister-Lewis, or any of them signing singly, and with full power

of substitution, the undersigned's true and lawful attorney-in-fact to:





(1) prepare, execute in the undersigned's name and on the undersigned's behalf,

and submit to the U.S. Securities and Exchange Commission (the "SEC") a

Form ID, including amendments thereto, and any other documents necessary or

appropriate to obtain codes and passwords enabling the undersigned to make

electronic filings with the SEC of reports required by Section 16(a) of the

Securities Exchange Act of 1934 (the "Exchange Act") or any rule or regulation

of the SEC;





(2) execute for and on behalf of the undersigned, in the undersigned's capacity

as a director and/or officer of Valeant Pharmaceuticals International, Inc.

(the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the

Exchange Act and the rules thereunder;





(3) do and perform any and all acts for and on behalf of the undersigned which

may be necessary or desirable to complete and execute any such Form 3, 4, or 5,

complete and execute any amendment or amendments thereto, and timely file

such form with the SEC and any stock exchange or similar authority; and





(4) take any other action of any type whatsoever in connection with the

foregoing which, in the opinion of such attorney-in-fact, may be of benefit

to, in the best interest of, or legally required by, the undersigned, it being

understood that the documents executed by such attorney-in-fact on behalf of

the undersigned pursuant to this Power of Attorney shall be in such form and

shall contain such terms and conditions as such attorney-in-fact may approve

in such attorney-in-fact's discretion.





The undersigned hereby grants to each such attorney-in-fact full power

and authority to do and perform any and every act and thing whatsoever

requisite, necessary, or proper to be done in the exercise of any of the

rights and powers herein granted, as fully to all intents and purposes as the

undersigned might or could do if personally present, with full power of

substitution or revocation, hereby ratifying and confirming all that such

 attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall

lawfully do or cause to be done by virtue of this power of attorney and the

rights and powers herein granted. The undersigned acknowledges that the

foregoing attorneys-in-fact, in serving in such capacity at the request of the

undersigned, are not assuming, nor is the Company assuming, any of the

undersigned's responsibilities to comply with  Section 16 of the Exchange Act.







This Power of Attorney shall remain in full force and effect until the

undersigned is no longer required to file Forms 3, 4, and 5 with

respect to the undersigned's holdings of and transactions in securities

issued by the Company, unless earlier revoked by the undersigned in a signed

writing delivered to the foregoing attorneys-in-fact.











[REMAINDER OF PAGE LEFT BLANK INTENTIONALY]



  IN WITNESS WHEREOF, the undersigned has caused this Power of

Attorney to be executed as of this 16th of March, 2017





/s/Paul Herendeen

Signature



Paul Herendeen

Name

You May Also Be Interested In

• SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg
• RenovoRx regains Nasdaq minimum bid price compliance
• Kairos Pharma announces 1-for-7 reverse stock split